Each quarter Locust Walk experts compile key statistics and trends on strategic transactions and financings. Our Q3 report uses the latest data to analyze current trends in the life science deal landscape. In this report you can find an overview and analysis of:...

Raising capital for an emerging biotech company is rarely easy. Tremendous time and effort goes into crafting the perfect story, determining the amount of capital you need to raise and what that money will be used for and reaching out to investors. It can be a long...

Though often overlooked or made by default, decisions about the structure and timing of a competitive deal process can have a significant impact on the ultimate value realized by the sell-side company. There are many important decisions that must be made in the...

GTC Bio Cell & Gene Therapy Summit was held on September 11-12, 2017 in Boston, MA. This meeting brought together academia and industry to showcase several new technologies emerging in the field of cell and gene therapy. Nick DeLong, Assocaite at Locust Walk...